Who
Anthony P. Adamis
Director
Company insider
Files Form 4 as: Director, Kalaris Therapeutics; Director, EyePoint.
In numbers
- Trades disclosed
- 14
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 23 Jun 2022
- Last trade
- 3 Jun 2026
- Last filed
- 4 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Jun 2026filed 4 Jun 2026 | KLRS Kalaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,000 at $0.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | KLRS Kalaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,000 at $0.00 | filing |
| 10 Apr 2025filed 11 Apr 2025 | KLRS Kalaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,000 at $0.00 | filing |
| 18 Mar 2025filed 18 Mar 2025 | KLRS Kalaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,484 | filing |
| 18 Mar 2025filed 18 Mar 2025 | KLRS Kalaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,989 | filing |
| 23 Jun 2024filed 25 Jun 2024 | EYPT EyePointoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,000 at $0.00 | filing |
| 23 Jun 2024filed 25 Jun 2024 | EYPT EyePointBiotechnology | SEC FORM 4 Code M | —2,000 at $0.00 | filing |
| 5 Jan 2024filed 9 Jan 2024 | EYPT EyePointoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,014 at $0.00 | filing |
| 23 Jun 2023filed 26 Jun 2023 | EYPT EyePointoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,000 at $0.00 | filing |
| 23 Jun 2023filed 26 Jun 2023 | EYPT EyePointBiotechnology | SEC FORM 4 Code M | —2,000 at $0.00 | filing |
| 20 Jun 2023filed 22 Jun 2023 | EYPT EyePointoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,100 at $0.00 | filing |
| 20 Jun 2023filed 22 Jun 2023 | EYPT EyePointoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,000 at $0.00 | filing |
| 23 Jun 2022filed 27 Jun 2022 | EYPT EyePointoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 23 Jun 2022filed 27 Jun 2022 | EYPT EyePointoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.